Tricyclic Pyrimidines As Inhibitors of DYRK1A/DYRK1B As Potential Treatment for Down's Syndrome or Alzheimer's Disease

ACS Med Chem Lett. 2013 Apr 26;4(6):502-3. doi: 10.1021/ml400137s. eCollection 2013 Jun 13.

¹ Structure Guided Chemistry, Dart Neuroscience LLC , 7473 Lusk Boulevard, San Diego, California 92121, United States, and Adjunct Associate Professor, Department of Pharmacology and Physiology, College of Medicine, Drexel University , New College Building, 245 North 15th Street, Philadelphia, Pennsylvania 19102, United States.

No abstract available